Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.00016 | 1 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.00011 | 1 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |